Noncoding RNA-mediated macrophage and cancer cell crosstalk in hepatocellular carcinoma
- PMID: 35506150
- PMCID: PMC9024380
- DOI: 10.1016/j.omto.2022.03.002
Noncoding RNA-mediated macrophage and cancer cell crosstalk in hepatocellular carcinoma
Abstract
The tumor microenvironment (TME) is a well-recognized system that plays an essential role in tumor initiation, development, and progression. Intense intercellular communication between tumor cells and other cells (especially macrophages) occurs in the TME and is mediated by cell-to-cell contact and/or soluble messengers. Emerging evidence indicates that noncoding RNAs (ncRNAs) are critical regulators of the relationship between cells within the TME. In this review, we provide an update on the regulation of ncRNAs (primarily micro RNAs [miRNAs], long ncRNAs [lncRNAs], and circular RNAs [circRNAs]) in the crosstalk between macrophages and tumor cells in hepatocellular carcinoma (HCC). These ncRNAs are derived from macrophages or tumor cells and act as oncogenes or tumor suppressors, contributing to tumor progression not only by regulating the physiological and pathological processes of tumor cells but also by controlling macrophage infiltration, activation, polarization, and function. Herein, we also explore the options available for clinical therapeutic strategies targeting crosstalk-related ncRNAs to treat HCC. A better understanding of the relationship between macrophages and tumor cells mediated by ncRNAs will uncover new diagnostic biomarkers and pharmacological targets in cancer.
Keywords: circular RNA (circRNA); hepatocellular carcinoma (HCC); long noncoding RNA (lncRNA); microRNA (miRNA); noncoding RNA (ncRNA); tumor microenvironment (TME); tumor-associated macrophage (TAM).
© 2022 The Authors.
Conflict of interest statement
The authors declare no competing interests.
Figures







Similar articles
-
Non-coding RNAs and macrophage interaction in tumor progression.Crit Rev Oncol Hematol. 2022 May;173:103680. doi: 10.1016/j.critrevonc.2022.103680. Epub 2022 Apr 9. Crit Rev Oncol Hematol. 2022. PMID: 35405273 Review.
-
The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment.Front Immunol. 2022 Feb 23;13:847728. doi: 10.3389/fimmu.2022.847728. eCollection 2022. Front Immunol. 2022. PMID: 35281015 Free PMC article. Review.
-
Advances and challenges of exosome-derived noncoding RNAs for hepatocellular carcinoma diagnosis and treatment.Biochem Biophys Rep. 2024 Mar 24;38:101695. doi: 10.1016/j.bbrep.2024.101695. eCollection 2024 Jul. Biochem Biophys Rep. 2024. PMID: 38560049 Free PMC article. Review.
-
Noncoding RNA (ncRNA)-mediated regulation of TLRs: critical regulator of inflammation in tumor microenvironment.Med Oncol. 2025 Mar 31;42(5):144. doi: 10.1007/s12032-025-02690-9. Med Oncol. 2025. PMID: 40163200 Review.
-
Noncoding RNAs: Regulating the crosstalk between tumor-associated macrophages and gastrointestinal cancer.Biomed Pharmacother. 2022 Sep;153:113370. doi: 10.1016/j.biopha.2022.113370. Epub 2022 Jul 2. Biomed Pharmacother. 2022. PMID: 35792392 Review.
Cited by
-
Biological impact and therapeutic implication of tumor-associated macrophages in hepatocellular carcinoma.Cell Death Dis. 2024 Jul 12;15(7):498. doi: 10.1038/s41419-024-06888-z. Cell Death Dis. 2024. PMID: 38997297 Free PMC article. Review.
-
Hypoxia-induced circRNAs encoded by PPARA are highly expressed in human cardiomyocytes and are potential clinical biomarkers of acute myocardial infarction.Eur J Med Res. 2024 Mar 12;29(1):159. doi: 10.1186/s40001-024-01753-3. Eur J Med Res. 2024. PMID: 38475969 Free PMC article.
-
Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications.Front Oncol. 2023 Sep 8;13:1256537. doi: 10.3389/fonc.2023.1256537. eCollection 2023. Front Oncol. 2023. PMID: 37746261 Free PMC article. Review.
-
LINC00330/CCL2 axis-mediated ESCC TAM reprogramming affects tumor progression.Cell Mol Biol Lett. 2024 May 20;29(1):77. doi: 10.1186/s11658-024-00592-8. Cell Mol Biol Lett. 2024. PMID: 38769475 Free PMC article.
-
The Early Peritoneal Cavity Immune Response to Vibrio Anguillarum Infection and to Inactivated Bacterium in Olive Flounder (Paralichthys olivaceus).Microorganisms. 2022 Nov 2;10(11):2175. doi: 10.3390/microorganisms10112175. Microorganisms. 2022. PMID: 36363767 Free PMC article.
References
-
- Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394–424. - PubMed
-
- Bruix J., Reig M., Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology. 2016;150:835–853. - PubMed
-
- Llovet J.M., Kelley R.K., Villanueva A., Singal A.G., Pikarsky E., Roayaie S., Lencioni R., Koike K., Zucman-Rossi J., Finn R.S. Hepatocellular carcinoma. Nat. Rev. Dis. Primers. 2021;7:6. - PubMed
-
- Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2019. CA Cancer J. Clin. 2019;69:7–34. - PubMed
Publication types
LinkOut - more resources
Full Text Sources